Navigation Links
Lilly and MacroGenics Announce Licensing and Collaboration Agreement
Date:10/18/2007

-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at http://www.lilly.com.

About MacroGenics, Inc.

Founded in 2000, MacroGenics is a private, venture-backed biotechnology company headquartered in Rockville, Maryland that focuses on the development, manufacture, and commercialization of immunotherapeutics for autoimmune disorders, cancer and infectious diseases. The company's proprietary Fc engineering technology offers ways of improving antibody function, such as enhancing the antibody's ability to eliminate cancer cells, cells that contribute to autoimmune disorders, or those infected with certain pathogens. The company is developing first-in-class product candidates from its autoimmunity, oncology and infectious disease portfolios. For more information about MacroGenics, please visit http://www.macrogenics.com.

This news release contains forward-looking statements. These statements are subject to known and unknown risks and uncertainties that may cause actual future experience and results to differ materially from the statements made. Factors that might cause such a difference include, among others, the completion of clinical trials, the FDA and other foreign review processes and other governmental regulation, Lilly and MacroGenics' abilities to successfully develop and commercialize drug candidates, competition from other pharmaceutical companies, the ability to effectively market products, and other factors described in Lilly's most recent filings with the Securities and Exchange Commission. Lilly undertakes no duty to update forward lo
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Animal insulin product to be discontinued by drug major Eli Lilly
2. Did Eli Lilly Turn Wily With Regard to Their Best-selling Schizophrenia Drug?
3. Eli Lilly Releases Digital Insulin Pen
4. OHSU Researchers Announce New Discovery
5. PM announces a new health care order for India
6. Partnership Between Diabetes India And Elsevier Announced
7. US Politicians Urge Movie Moghuls To Add Anti-Smoking Announcements
8. Ramdoss Announces Introduction of RCH-II
9. Britain Announces Third Transfusion Related Mad Cow Case
10. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
11. Tibet Announces the Dalai Lama’s Tour of South Americ
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... 26, 2015 Dr. Alex Rabinovich and ... announce expanded offerings for Bay Area patients considering dental ... Center has long been a top-rated center, serving primarily ... to meet the strong demand by others throughout Northern ... a top-rated dental implant facility in San Francisco,”explained Dr. ...
(Date:3/26/2015)... March 26, 2015 Pacific Medical LLC, ... pleased to be featured on Innovations with Ed Begley ... 18, 2015. The episode will repeat on local ... on the Pacific Medical home page at: http://www.pacificmedicalsupply.com ... emergencies, it is reassuring to trust the integrity of ...
(Date:3/26/2015)... Altamonte Springs, FL (PRWEB) March 26, 2015 ... one of the nation’s leading innovative specialty pharmacies, ... newly created position of Vice President of Pharmaceutical ... for fostering beneficial connections with our pharmaceuticals partners ... pharmaceutical relationships in support of BioPlus’ expansion. ...
(Date:3/26/2015)... (PRWEB) March 26, 2015 The ... for Assessment and Evaluation , has announced its ... enable institutions, organizations, and corporations to accurately and ... successful learning. , Utilizing Questionmark’s state-of-the-art software ... will offer improved delivery of the seventy-five ...
(Date:3/26/2015)... In the key developed markets, the hypertension ... is set to decrease through 2020 at a negative CAGR ... expected up to 2017 at a 2.6% CAGR and a ... to the surging penetration of fixed-dose combination drugs like Azor, ... Benicar HCT, and Tekamlo), a hike in the prevalence population ...
Breaking Medicine News(10 mins):Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 2Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 3Health News:Pacific Medical Featured on the Discovery Channel 2Health News:Pacific Medical Featured on the Discovery Channel 3Health News:BioPlus Specialty Pharmacy Expands Executive Team with New Position, Naming Sharon Ferrer as Vice President of Pharmaceutical Relations 2Health News:NLN Testing Services Announces Improved Delivery and Analytics Software and Newly Developed and Revised Exams 2Health News:Top 8 Developed Anti-Hypertensive Therapeutics Markets Discussed in New GBI Research Report Published at MarketPublishers.com 2Health News:Top 8 Developed Anti-Hypertensive Therapeutics Markets Discussed in New GBI Research Report Published at MarketPublishers.com 3
... repeat problems seen in 1976 episode , TUESDAY, July ... in 1976 to vaccinate 43 million people against swine ... the dreaded outbreak never materialize (illness never spread beyond ... 500 Americans who did get vaccinated came down with ...
... , Innovative child welfare practices from across ... , , SEATTLE, July 21 ... way they do business. These changes are improving the lives of children ... care. , , (Logo: ...
... AlphaRx plans to open an R&D facility and manufacturing plant ... innovative drug products to the fastest, growing ... July 21 /PRNewswire-FirstCall/ - AlphaRx (OTC BB:ALRX - News), an ... novel formulations of drugs, is forging ahead with its growth ...
... , , Clinical ... inspections , , Washington, ... the same safety, ethical and quality standards as those conducted in ... report released today by the Association of Clinical Research Organizations (ACRO). ...
... , , BALTIMORE, July 21 ... to people that want to take control of their health, and ... to employers announced that they have reached an agreement to bring ... their employees - "stay healthy." , , ...
... , SCOTTSDALE, Ariz., July 21 ... in their personal expenses. No longer are trendy fashion statements considered ... into aesthetic treatments aimed at improving or enhancing appearance, and those ... , Suggestions to make the most of your beauty ...
Cached Medicine News:Health News:Safety of Swine Flu Vaccine to Face Tough Scrutiny 2Health News:Safety of Swine Flu Vaccine to Face Tough Scrutiny 3Health News:Safety of Swine Flu Vaccine to Face Tough Scrutiny 4Health News:New Report Sets a Course for Improving Foster Care Systems 2Health News:New Report Sets a Course for Improving Foster Care Systems 3Health News:AlphaRx Unveils its China Strategy 2Health News:Clinical Research Safety and Ethical Standards in Developing World Up to U.S. Levels, Report Says 2Health News:Clinical Research Safety and Ethical Standards in Developing World Up to U.S. Levels, Report Says 3Health News:Clinical Research Safety and Ethical Standards in Developing World Up to U.S. Levels, Report Says 4Health News:Clinical Research Safety and Ethical Standards in Developing World Up to U.S. Levels, Report Says 5Health News:Stayhealthy and Innovative Wellness Solutions Announce Partnership to Bring Innovation to the Workplace Wellness Market 2Health News:Stayhealthy and Innovative Wellness Solutions Announce Partnership to Bring Innovation to the Workplace Wellness Market 3Health News:The Secrets to Staying Beautiful; Making the Most of Your Beauty Budget 2Health News:The Secrets to Staying Beautiful; Making the Most of Your Beauty Budget 3
(Date:3/26/2015)... March 26, 2015  Oxis Biotech, Inc. ... International, Inc. [OTC: OXIS] and [Euronext Paris: ... exclusive option agreement with the University of ... by Dr. Xiang-Qun Xie , Associate ... Sciences, School of Pharmacy.  These patents/intellectual properties ...
(Date:3/26/2015)... BUENA, N.J. , March 26, 2015 ... New Jersey based specialty generic pharmaceutical company, ... drug application (ANDA) to the U.S. Food and Drug ... number of ANDA submissions now pending at the FDA ... and CEO of the Company, commented, "On March 2, ...
(Date:3/26/2015)... , March 26, 2015  CNBC profiled MJ Freeway ... part of a series "How I Did It," which features ... the High Road" released yesterday, illustrates how two tech ... leading IT providers to the marijuana industry. ... describes how Co-Founders Amy Poinsett and Jessica Billingsley ...
Breaking Medicine Technology:Oxis Biotech Executes Option Agreement to Certain Patents/Intellectual Properties Owned by the University of Pittsburgh 2Oxis Biotech Executes Option Agreement to Certain Patents/Intellectual Properties Owned by the University of Pittsburgh 3IGI Laboratories, Inc. Announces First ANDA Submission Of 2015 2MJ Freeway, Industry-Leading Software Solution for Cannabis Businesses, Featured in CNBC Special "How I Did It" 2
This is an Immunological assay intended for the quantitative in vitro determination of haemoglobin A1c (HbA1c) in whole blood....
For the quantitative in vitro determination of Sodium in serum and plasma....
Immunoturbidimetric assay for the quantitative in vitro determination of Lipoprotein (a) in human serum or plasma...
Immunoturbidimetric assay for the quantitative in vitro determination of Lipoprotein (a) in human serum or plasma...
Medicine Products: